RxDoctor Payments Data

Brooke Messer

Optometrist · West Fargo, NDNPI 1114239282

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Bausch & Lomb Americas Inc. accounts for 67.1% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $76,850, 4.6 times the $16,661 reported in 2019. Among optometrist clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$263,040in general payments, 2019–2025

Across 295 payments — averaging $891.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$176K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$54K
  • Glaukos Corporation$27K
  • Heidelberg Engineering, Inc.$2K
  • Coopervision Inc.$1K
  • Alcon$586
  • plus $2K from 21 others
$37,850in research payments, 2019–2025

Across 6 payments — averaging $6308.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch Health US, LLC$38K

What the payments were for

  • Consulting fees$134,42751%
  • Speaking & faculty fees$95,00036%
  • Travel & lodging$27,96911%
  • Food & beverage$5,5512%
  • Education$930%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$263,040 in reported general payments places this provider in the 95th percentile of 179 optometrist providers in North Dakota.

See all optometrist providers in North Dakota

Medicare billing

Part B allowed, 2024
$46,265
Medicare patients
204
Services billed
496

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Difluprednate43$5,180
Prednisolone Acetate48$2,233
Travoprost11$1,268
MoxifloxacinMoxifloxacin Hcl43$772
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat12$268
Ketorolac Tromethamine14$167

Paid to pharmacies, not to this prescriber.

Other optometrist in West Fargo

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →